US RNA interference (RNAi)specialist Arrowhead Pharmaceuticals (Nasdaq: ARWR) today announced that its majority-owned subsidiary Visirna Therapeutics has signed an asset purchase agreement with France ...

Swedish biotech Oncopeptides (Nasdaq Stockholm: ONCO) has entered into a partnership with Spanish pharmaceutical broker SD Pharma to boost the availability of its cancer drug Pepaxti (melphalan ...

A new real-world analysis from UK drugmaker Indivior (Nasdaq: INDV) suggests that patients with opioid use disorder (OUD) treated with its once-monthly injectable buprenorphine formulation, BUP-XR, ...

The US Food and Drug Administration has set prescription drug user fee rates for fiscal year 2026, with increases across all key categories under the Prescription Drug User Fee Act (PDUFA) VII.

The US Food and Drug Administration (FDA) issued a press release late Friday announcing an investigation into the death of an eight-year-old Duchenne muscular dystrophy (Duchenne) patient who had ...

Russian nano giant Rusnano is cutting its pharmaceutical business by beginning a search for buyers for its major pharmaceutical asset – the local drugmaker Novamedica, The Pharma Letter’s local ...

Hospitals are rationing cancer treatments. Pharmacies are scrambling to fill routine antibiotic prescriptions. And across the USA, patients are facing growing delays, substitutions, or outright ...

Jiangsu Hengrui Pharmaceuticals shares rallied to their highest level in four years – leaping 10% to 62.04 renminbi - after UK pharma major GSK announced a deal with the Chinese company.

For millions in low- and middle-income countries (LMICs), lifesaving medicines remain out of reach. While the pharmaceutical industry continues to deliver record-breaking innovation, access to those ...

BJS Biotechnologies was created to create and develop ultra-high speed thermocycling technology and apply it to Polymerase Chain Reaction (PCR) tests such as its flagship xxpress product, claimed to ...

Barbara Obstoj-Cardwell is the Managing Editor of The Pharma Letter, which in 2010 acquired the archives of The Pharma Marketletter, a publication that Barbara owned since 1991 and prior to that ...

Simon Wentworth is a journalist and digital news editor at The Pharma Letter. Part of the editorial team since 2017, Simon is host of The Pharma Letter Podcast and has reported from major European and ...